Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
12%
ALSO IN XPH
XPH
47
HOLDINGS
15%
ALSO IN XLV
SECTOR DRIFT (XLV minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.4% | 2.8% | 2.8% |
|
JOHNSON & JOHNSON | 8.6% | 2.7% | 2.7% |
|
MERCK & CO. INC. | 4.1% | 2.6% | 2.6% |
|
PFIZER INC | 2.7% | 2.6% | 2.6% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% | 2.4% | 1.7% |
XLV Overweight Relative to XPH
|
ELI LILLY & CO | 9.6% |
|
ABBVIE INC | 7.6% |
|
UNITEDHEALTH GROUP INC | 6.2% |
|
JOHNSON & JOHNSON | 5.9% |
|
ABBOTT LABORATORIES | 4.2% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
INTUITIVE SURGICAL INC | 3.7% |
|
AMGEN INC | 3.0% |
|
GILEAD SCIENCES INC | 2.8% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
XLV Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.1% |
|
ELANCO ANIMAL HEALTH, INC. | -3.0% |
|
CRINETICS PHARMACEUTICALS INC | -3.0% |
|
SUPERNUS PHARMACEUTICALS INC | -2.9% |
|
LIGAND PHARMACEUTICALS-CL B | -2.9% |
 |
JAZZ PHARMACEUTICALS PLC | -2.8% |
|
AXSOME THERAPEUTICS, INC. | -2.6% |
|
ROYALTY PHARMA PLC CLASS A | -2.6% |
|
CORCEPT THERAPEUTICS INC | -2.6% |
|
PERRIGO CO | -2.5% |